Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients

Ulcerative Colitis (UC) is an inflammatory bowel disease typically affecting the colon. Patients with active UC have elevated tumor necrosis factor (TNF) concentrations in serum and colonic tissue. Infliximab is a monoclonal antibody directed against TNF and binds with high affinity. Target-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Berends, Sophie E., van Steeg, Tamara J., Ahsman, Maurice J., Singh, Sharat, Brandse, Johannan F., D’Haens, Geert R. A. M., Mathôt, Ron A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868113/
https://www.ncbi.nlm.nih.gov/pubmed/31489538
http://dx.doi.org/10.1007/s10928-019-09652-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868113/
https://www.ncbi.nlm.nih.gov/pubmed/31489538
http://dx.doi.org/10.1007/s10928-019-09652-5

Ejemplares similares